ATE334983T1 - Spirosubstituierte piperidine als selektive antagonisten des melanin konzentrierenden hormon rezeptors für die behandlung von fettleibigkeit - Google Patents
Spirosubstituierte piperidine als selektive antagonisten des melanin konzentrierenden hormon rezeptors für die behandlung von fettleibigkeitInfo
- Publication number
- ATE334983T1 ATE334983T1 AT03762050T AT03762050T ATE334983T1 AT E334983 T1 ATE334983 T1 AT E334983T1 AT 03762050 T AT03762050 T AT 03762050T AT 03762050 T AT03762050 T AT 03762050T AT E334983 T1 ATE334983 T1 AT E334983T1
- Authority
- AT
- Austria
- Prior art keywords
- spiro
- obesity
- treatment
- hormone receptor
- substituted piperidine
- Prior art date
Links
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical class C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 2
- 102000029828 Melanin-concentrating hormone receptor Human genes 0.000 title 1
- 108010047068 Melanin-concentrating hormone receptor Proteins 0.000 title 1
- 208000008589 Obesity Diseases 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39181302P | 2002-06-27 | 2002-06-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE334983T1 true ATE334983T1 (de) | 2006-08-15 |
Family
ID=30000757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03762050T ATE334983T1 (de) | 2002-06-27 | 2003-06-26 | Spirosubstituierte piperidine als selektive antagonisten des melanin konzentrierenden hormon rezeptors für die behandlung von fettleibigkeit |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7109207B2 (enExample) |
| EP (1) | EP1532147B1 (enExample) |
| JP (1) | JP4522853B2 (enExample) |
| CN (1) | CN100374440C (enExample) |
| AR (1) | AR040344A1 (enExample) |
| AT (1) | ATE334983T1 (enExample) |
| AU (1) | AU2003258957A1 (enExample) |
| CA (1) | CA2490531C (enExample) |
| DE (1) | DE60307289T2 (enExample) |
| ES (1) | ES2266861T3 (enExample) |
| MX (1) | MXPA05000185A (enExample) |
| PE (1) | PE20040749A1 (enExample) |
| TW (1) | TW200401777A (enExample) |
| WO (1) | WO2004002987A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002352878B2 (en) | 2001-11-27 | 2007-11-22 | Merck Sharp & Dohme Corp. | 2-Aminoquinoline compounds |
| AU2004209505B2 (en) | 2003-02-10 | 2009-07-23 | Banyu Pharmaceutical Co., Ltd. | Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| EP1601664B1 (en) * | 2003-02-28 | 2008-04-30 | Schering Corporation | Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
| WO2005092858A2 (en) | 2004-03-29 | 2005-10-06 | Pfizer Japan Inc. | Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist |
| TW200630337A (en) * | 2004-10-14 | 2006-09-01 | Euro Celtique Sa | Piperidinyl compounds and the use thereof |
| EP1867341A4 (en) * | 2005-03-29 | 2009-07-29 | Banyu Pharma Co Ltd | THERAPEUTIC AGENT FOR NON-ALCOHOLIC FATBERS AND SCREENING METHODS FOR A DRUG-RELATED BIO-TREATMENT FOR THE TREATMENT OR PREVENTION OF NON-ALCOHOLIC FATERS |
| WO2007110449A1 (en) * | 2006-03-29 | 2007-10-04 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use |
| WO2007118853A1 (en) * | 2006-04-13 | 2007-10-25 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use as blockers of calcium channels |
| TW200812963A (en) * | 2006-04-13 | 2008-03-16 | Euro Celtique Sa | Benzenesulfonamide compounds and the use thereof |
| EP2072519A4 (en) * | 2006-09-28 | 2009-10-21 | Banyu Pharma Co Ltd | DIARYLKETIMINDERIVAT |
| WO2008124118A1 (en) * | 2007-04-09 | 2008-10-16 | Purdue Pharma L.P. | Benzenesulfonyl compounds and the use therof |
| WO2009040659A2 (en) * | 2007-09-28 | 2009-04-02 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
| US9090084B2 (en) | 2010-05-21 | 2015-07-28 | Hewlett-Packard Development Company, L.P. | Fluid ejection device including recirculation system |
| US9963739B2 (en) | 2010-05-21 | 2018-05-08 | Hewlett-Packard Development Company, L.P. | Polymerase chain reaction systems |
| JP2017535545A (ja) * | 2014-11-21 | 2017-11-30 | ラボラトリオス・デル・デエレ・エステベ・エセ・ア | 疼痛に対する多様な活性を有するスピロ−イソキノリン−１，４’−ピペリジン化合物 |
| CN107312056B (zh) * | 2017-08-24 | 2019-10-25 | 广西师范学院 | 2-(3’-羟基-17’-孕甾烷基)-5-氟苯并咪唑的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5908830A (en) | 1996-10-31 | 1999-06-01 | Merck & Co., Inc. | Combination therapy for the treatment of diabetes and obesity |
| TWI279402B (en) * | 1999-08-20 | 2007-04-21 | Banyu Pharma Co Ltd | Spiro compounds having NPY antagonistic activities and agents containing the same |
| WO2001013917A1 (en) * | 1999-08-26 | 2001-03-01 | Bristol-Myers Squibb Company | Npy antagonists: spiroisoquinolinone derivatives |
| JP2003527444A (ja) | 2000-03-23 | 2003-09-16 | メルク エンド カムパニー インコーポレーテッド | メラノコルチン受容体アゴニストとして作用するスピロピペリジン誘導体 |
| EP1299362A4 (en) * | 2000-07-05 | 2004-11-03 | Synaptic Pharma Corp | SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE |
-
2003
- 2003-06-26 CN CNB038151936A patent/CN100374440C/zh not_active Expired - Fee Related
- 2003-06-26 AT AT03762050T patent/ATE334983T1/de not_active IP Right Cessation
- 2003-06-26 ES ES03762050T patent/ES2266861T3/es not_active Expired - Lifetime
- 2003-06-26 WO PCT/US2003/020088 patent/WO2004002987A1/en not_active Ceased
- 2003-06-26 CA CA2490531A patent/CA2490531C/en not_active Expired - Fee Related
- 2003-06-26 JP JP2004517838A patent/JP4522853B2/ja not_active Expired - Fee Related
- 2003-06-26 DE DE60307289T patent/DE60307289T2/de not_active Expired - Lifetime
- 2003-06-26 PE PE2003000647A patent/PE20040749A1/es not_active Application Discontinuation
- 2003-06-26 AU AU2003258957A patent/AU2003258957A1/en not_active Abandoned
- 2003-06-26 EP EP03762050A patent/EP1532147B1/en not_active Expired - Lifetime
- 2003-06-26 TW TW092117445A patent/TW200401777A/zh unknown
- 2003-06-26 MX MXPA05000185A patent/MXPA05000185A/es active IP Right Grant
- 2003-06-26 US US10/607,051 patent/US7109207B2/en not_active Expired - Fee Related
- 2003-06-26 AR ARP030102294A patent/AR040344A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2266861T3 (es) | 2007-03-01 |
| PE20040749A1 (es) | 2004-10-23 |
| CA2490531C (en) | 2011-03-22 |
| DE60307289D1 (de) | 2006-09-14 |
| JP2005535641A (ja) | 2005-11-24 |
| AR040344A1 (es) | 2005-03-30 |
| US7109207B2 (en) | 2006-09-19 |
| DE60307289T2 (de) | 2007-10-18 |
| CN1665812A (zh) | 2005-09-07 |
| CN100374440C (zh) | 2008-03-12 |
| EP1532147A1 (en) | 2005-05-25 |
| JP4522853B2 (ja) | 2010-08-11 |
| TW200401777A (en) | 2004-02-01 |
| HK1071567A1 (en) | 2005-07-22 |
| CA2490531A1 (en) | 2004-01-08 |
| MXPA05000185A (es) | 2005-04-08 |
| WO2004002987A1 (en) | 2004-01-08 |
| US20040024002A1 (en) | 2004-02-05 |
| EP1532147B1 (en) | 2006-08-02 |
| AU2003258957A1 (en) | 2004-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60307289D1 (de) | Spirosubstituierte piperidine als selektive antagonisten des melanin konzentrierenden hormon rezeptors für die behandlung von fettleibigkeit | |
| DE60010722D1 (de) | Dibenzopyrane als glucocorticoid-rezeptor-antagonisten für die behandlung von zuckerkrankheit | |
| DE60130675D1 (de) | Selektive agonisten des ep4 rezeptors für die behandlung von osteoporose | |
| AU2003243497A8 (en) | Antagonists of melanin concentrating hormone receptor | |
| EA200300944A1 (ru) | Ацилированные пиперидиновые производные в качестве агонистов рецептора-4 меланокортина | |
| ATE474577T1 (de) | Bicyclische piperidin-derivate als melanocortin-4 rezeptor-agonisten | |
| DE60312999D1 (de) | Vorrichtung zum anbringen von nähten | |
| FI20050244L (fi) | Prosessi platinametallien talteenottamiseksi perusmetalleja sisältävästä materiaalista | |
| DE60032905D1 (de) | Selektive iglur5 rezeptorantagonisten zur behandlung der migräne | |
| DE60204951D1 (de) | Ccr5 antagonisten verwendbar für die behandlung von aids | |
| ATE429226T1 (de) | Verwendung von verbindungen, die als selektive opiat-rezeptor-modulatoren wirksam sind | |
| DE60309909D1 (de) | Glucocorticoidrezeptorliganden zur behandlung von stoffwechselstörungen | |
| MX2007004306A (es) | Compuestos biciclicos como antagonistas del receptor de la hormona concentradora de melanina selectivos para el tratamiento de la obesidad y trastornos relacionados. | |
| DE60302913D1 (de) | Erweiterung des Befehlssatzes zum software-initiierten Vorausladen | |
| DE60238709D1 (de) | 4-piperidinylalkylamin-derivate, antagonisten von muscarinrezeptoren | |
| ATE393766T1 (de) | Biaryltetrahydroisochinolin-piperidine als selektive mch-rezeptor-antagonisten zur behandlung von adipositas und verwandten erkrankungen | |
| EP1781316A4 (en) | CYCLIC PEPTIDES FOR THE TREATMENT OF CACHEXIA | |
| NO20053490D0 (no) | Methods for prediciting therapeutic response to agents acting on the growth hormone receptor | |
| ATE512959T1 (de) | 2-substituierte benzimidazolpiperidinanaloga als selektive antagonisten des auf das melanin- konzentrierende hormon wirkenden rezeptors zur behandlung von obesitas und verwandten erkrankungen | |
| DE60330528D1 (de) | Kontakthärtende Dentalstiftzemente und Verfahren zum Anbringen von Dentalstiften | |
| DE50301116D1 (de) | 9-alpha-substituierte estratriene als selektiv wirksame estrogene | |
| DE50306736D1 (de) | Rahmen für Sessel von Sesselliften | |
| NO20052012L (no) | Indoler nyttige for behadling av androgen-reseptor relaterte sykdommer | |
| ATE432702T1 (de) | Aminobenzimidazole als selektive melanin- konzentrierende hormon-rezeptorantagonisten zur behandlung von fettsucht und verwandten erkrankungen | |
| ATE335500T1 (de) | Die verwendung von antagonisten des bradykinin-b2 rezeptors zur behandlung von osteoarthrose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |